首页> 美国卫生研究院文献>Bioengineered >miR-25-3p inhibition impairs tumorigenesis and invasion in gastric cancer cells in vitro and in vivo
【2h】

miR-25-3p inhibition impairs tumorigenesis and invasion in gastric cancer cells in vitro and in vivo

机译:miR-25-3p抑制在体外和体内患有胃癌细胞中的肿瘤发生和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Deregulated expression of microRNAs (miRNAs) plays a role in the pathogenesis and progression of gastric cancer (GC). Among upregulated miRNAs, miR-25-3p has oncogenic potential and therefore represents an attractive target for the treatment of GC. Here, we investigated the role of miR-25-3p on GC cells in vitro and in vivo. We found that miR-25-3p overexpression significantly promoted growth and invasion of gastric cancer cells in vitro. Conversely, targeting miR-25-3p triggered significant inhibition of growth, invasion and migration in GC cells in vitro. In vivo delivery of miR-25-3p inhibitors induced significant anti-tumor activity in SCID mice bearing human GC xenografts. Our findings showed the evidence that in vivo antagonism of miR-25-3p impaired tumorigenesis, providing the rationale for clinical development of miR-25-3p inhibitors in GC.
机译:MicroRNA(miRNA)的Deroigation表达在胃癌(GC)的发病机制和进展中起作用。在上调的miRNA中,miR-25-3p具有致癌潜力,因此代表了治疗GC的有吸引力的靶标。在这里,我们在体外和体内调查了miR-25-3p对GC细胞的作用。我们发现miR-25-3p过表达在体外显着促进了胃癌细胞的生长和侵袭。相反,靶向miR-25-3p在体外触发GC细胞中生长,侵袭和迁移的显着抑制。体内递送miR-25-3p抑制剂在含人GC异种移植物的SCID小鼠中诱导显着的抗肿瘤活性。我们的研究结果表明,MIR-25-3P肿瘤发生的体内拮抗作用,提供了GC中MIR-25-3P抑制剂的临床开发理由。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号